MustGrow Biologics Corp. (MGROF)
OTCQB OTCQB Primary 
MustGrow Biologics eyes strong finish to 2025 as it grows revenue, margins during Q3
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF), a provider of regenerative agriculture solutions, reported record third quarter financial results as it expands its presence in Canadian and US markets. Revenue was $0.8 million for the quarter, compared with no revenue in the year-ago period.
MustGrow Biologics reports record second quarter revenue
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF), a provider of innovative regenerative agriculture solutions, has reported record revenue for the second quarter, with sales of $2.8 million for the three months ended June 30, 2025. This compares with no recorded revenue in the same quarter of 2024.
MustGrow Biologics launches $3M private placement
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said on Wednesday it plans to raise up to C$3 million through a non-brokered private placement, as the agricultural biotech firm looks to ramp up production of its mustard-derived soil bioproducts. The financing will see the company issue up to 4.29 million units at C$0.70 each, with each unit comprising one common share and one five-year warrant exercisable at C$0.90.
MustGrow Biologics enhances exposure to key Canadian phosphate market with RhizoSorb deal
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has “added another arrow to its NexusBioAg product quiver,” with the signing of a distribution agreement with Phospholutions, analysts at Noble Capital Markets believe. The new agreement broadens NexusBioAg's offerings with the company to sell Phospholutions' RhizoSorb product in Canada.
MustGrow to distribute Phospholutions' RhizoSorb fertilizer efficiency product in Canada
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said on Tuesday it has entered into a distribution agreement with US-based Phospholutions to bring RhizoSorb phosphorus efficiency technology to the Canadian market. Under the agreement, MustGrow will market and sell RhizoSorb through its sales and distribution division, NexusBioAg.
MustGrow Biologics posts first significant revenue in ‘pivotal' Q1 report
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)' first quarter 2025 earnings report was a pivotal milestone for the company as it reported significant sales revenue for the first time, analysts at Nobel Capital Markets have highlighted. Q1 marked the first full quarter since the company acquired NexusBioAg at the end of 2024.
MustGrow Biologics posts record first quarter revenue
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has reported first quarter revenue of $3.8 million, a record for the company. The developer of regenerative farming solutions posted a gross profit for the quarter of $541.221 at a 14.3% gross margin.
MustGrow expands product line with three new biological solutions
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has introduced three new biological products to its Canadian lineup following its acquisition of sales and distribution division NexusBioAg, the company said on Tuesday. The additions—EZ-Gro Max, EZ-Gro Cyto, and Rootella mycorrhizal inoculants—are designed to enhance crop health, increase yield potential, and improve resilience against environmental stress, MustGrow said in a statement.
MustGrow Biologics signs five-year deal for Canadian expansion - ICYMI
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson joined Proactive to discuss the company's latest five-year exclusive distribution agreement with Adjuvants Plus in Canada. Through its sales and distribution arm, NexusBioAg, MustGrow will now offer Adjuvants Plus products to Canadian farmers.
MustGrow distribution deal sets stage for successful US expansion, analysts believe
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) this week announced the signing of a five-year exclusive distribution agreement with Adjuvants Plus, a move welcomed by analysts at Noble Capital Markets. Per the agreement, MustGrow will distribute Adjuvants' product line across Canada through NexusBioAg.
MustGrow Biologics inks distribution deal with Adjuvants Plus
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has signed a five-year exclusive distribution agreement with Canadian regenerative agriculture firm Adjuvants Plus. The company said that through its recently acquired Canadian sales and distribution division, NexusBioAg, it will distribute Adjuvants' product line across the country.
MustGrow Biologics announces closing of financing round
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced the completion of its previously disclosed non-brokered private placement of units, raising $2,585,000. The proceeds of the offering will be used for inventory production of its biofertilizer offering TerraSante, working capital and general corporate purposes.
